Abstract:N-1-(deoxyfructosyl) valine of β-hemoglobin, commonly referred to as HbA1c, is the “gold standard” for clinical detection of diabetes. Instead of quantifying the full-length HbA1c glycated protein, in the present study, we proposed the peptide-based strategy to quantify the depletion of the tryptic peptides of hemoglobin for the diagnosis of type 2 diabetes mellitus (T2DM). The peptides were discovered and validated as T2DM biomarkers by label-free LC-ESI-DMRM method without reference material. The glucose could react with hemoglobin's free amino group of N-terminus and ϵ-amino group of lysine residues and leave the modification on the hemoglobin tryptic peptides. Thus, there are two types of peptides in the hemoglobin: sensitive peptides and insensitive peptides to glucose due to the differential sensitivity of lysine residues to glycation. To discover two types of peptides of hemoglobin, we first developed the assay of liquid chromatography-electrospray ionization mass spectrometry coupled with dynamic multiple reaction monitoring. The protein coverage reaches 94.2%. Moreover, the hemoglobin was incubated with the 500 mmol/L glucose for 20 days, 40 days and 60 days in vitro to screen the sensitive peptides and insensitive peptides to glucose. A total of 14 sensitive peptides and 4 insensitive peptides were discovered. Furthermore, the LC-ESI-DMRM method was also utilized to validated the glucose-sensitive peptides by 40 clinical samples with healthy control individuals (n = 20) and type 2 diabetes mellitus patients (n = 20). Three putative sensitive peptides (LLGNVLVCVLAHHFGK, VVAGVANALAHKYH, LRVDPVNFK) from the hemoglobin showed excellent sensitivity and specificity based on receiver operating characteristic analysis and were verified as the promising biomarkers for the diagnosis of diabetes mellitus. And one peptide (LLVVYPWTQR) was found as glucose-insensitive peptide. Taken together, the findings of this study suggest that quantification of hemoglobin tryptic peptides using label-free and standard-free LC-ESI-DMRM is an alternative method for the diagnosis of T2DM, which could be combined with other MS-based blood biomarkers for diagnosis of multiple diseases in MS single shot.

Determination of plasma methylglyoxal and glyoxal concentrations in patients with diabetes mellitus by high-performance liquid chromatographic/tandem mass spectrometry

Increased plasma levels of the methylglyoxal in patients with newly diagnosed type 2 diabetes 2.

Glyoxal and methylglyoxal as urinary markers of diabetes. Determination using a dispersive liquid-liquid microextraction procedure combined with gas chromatography-mass spectrometry

Elevated Levels of Α-Dicarbonyl Compounds in the Plasma of Type II Diabetics and Their Relevance with Diabetic Nephropathy.

Rapid determination of acetone in human plasma by gas chromatography-mass spectrometry and solid-phase microextraction with on-fiber derivatization.

Development of gas chromatography–mass spectrometry following headspace single-drop microextraction and simultaneous derivatization for fast determination of the diabetes biomarker, acetone in human blood samples

A New Strategy For Early Diagnosis Of Type 2 Diabetes By Standard-Free, Label-Free Lc-Ms/Ms Quantification Of Glycated Peptides

A Ratiometric Fluorescence Probe for Selective Detection of Ex Vivo Methylglyoxal in Diabetic Mice.

Application of a Pseudotargeted MS Method for the Quantification of Glycated Hemoglobin for the Improved Diagnosis of Diabetes Mellitus

LC–MS/MS for the simultaneous determination of polar endogenous ADMA and CML in plasma and urine from diabetics

HPLC–electrospray Tandem Mass Spectrometry for Simultaneous Quantitation of Eight Plasma Aminothiols: Application to Studies of Diabetic Nephropathy

Quantitation of L-arginine and Asymmetric Dimethylarginine in Human Plasma by LC-selective Ion Mode-Ms for Type 2 Diabetes Mellitus Study.

The Tryptic Peptides of Hemoglobin for Diagnosis of Type 2 Diabetes Mellitus Using Label-Free and Standard-Free LC-ESI-DMRM

GC-MS validation and analysis of targeted plasma metabolites related to carbonyl stress in type 2 diabetes mellitus patients with and without acute coronary syndrome

A high-throughput method for measurement of glycohemoglobin in blood samples utilizing laser-accelerated proteolysis and MALDI-TOF MS

Establishment of a Method to Detect the Level of Saliva 1,5-Anhydroglucitol

Determination of acetone in human breath by gas chromatography-mass spectrometry and solid-phase microextraction with on-fiber derivatization.

Plasma Targeted Metabolomics Analysis for Amino Acids and Acylcarnitines in Patients with Prediabetes, Type 2 Diabetes Mellitus, and Diabetic Vascular Complications

Simultaneous quantification of apolipoproteins A-I, E, and J in human plasma by LC-MS/MS for clinical application to diabetes mellitus complicated with cardiovascular disease

Sensitive Determination of Glucose in Dulbecco's Modified Eagle Medium by High-Performance Liquid Chromatography with 1-Phenyl-3-methyl-5-pyrazolone Derivatization: Application to Gluconeogenesis Studies.

Enzymatic detection of α-hydroxybutyrate, an important marker of insulin resistance, and comparison with LC-MS/MS detection